Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

LPC/siRNA nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

chondroitin sulfate/protamine-complexed anti-VEGF siRNA

chondroitin sulfate/protamine-complexed siVEGF
Type Biomolecule
Formula
Role core
2

mixture of substance based on (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy-poly(ethylene glycol)2000]/(2-aminoethoxy)({2,3-bis[(9Z)-octadec-9-enoyloxy]propoxy})phosphinic acid/N,N,N-trimethyl-2,3-bis[(9Z)-9-octadecenoyloxy]-1-propanaminium)

Type Complex Compound
Formula
Role layer
3

cholesterol

Type Single Compound
Formula C27H46O
Role loaded material

Properties

General physical and chemical properties

Property Value Source
stability dependent on serum concentration

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
female BALB/c nude mouse bearing human breast MCF-7 cancer

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • cholesterol
  • N,N,N-trimethyl-2,3-bis[(9Z)-9-octadecenoyloxy]-1-propanaminium
  • (2-aminoethoxy)({2,3-bis[(9Z)-octadec-9-enoyloxy]propoxy})phosphinic acid
Product

LPC/siRNA nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial